Who owns ALX ONCOLOGY HLDGS INC COM?
- Ticker: ALXO
- CUSIP Number: 00166b105
Tip: Access positions for across all investors
Analyze quarterly positions in Alx Oncology Hldgs with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Alx Oncology Hldgs stock
Who bought or sold ALX ONCOLOGY HLDGS INC COM this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| venBio Partners | 9.7M | $11M | 0% | Dec 2025 |
|
| Redmile Group | 3.3M | $6.1M | -2% | Sep 2025 |
|
| Millennium Management | 2.7M | $4.9M | 441% | Sep 2025 |
|
| Almitas Capital | 2.5M | $2.9M | 0% | Dec 2025 |
|
| Vanguard Group | 1.6M | $1.8M | 7% | Dec 2025 |
|
| Acadian Asset Management | 1.4M | $1.6M | 13% | Dec 2025 |
|
| UBS Group | 866k | $979k | 402% | Dec 2025 |
|
| Driehaus Capital Management | 796k | $1.5M | 100% | Sep 2025 |
|
| Two Sigma Advisers | 720k | $1.3M | 2% | Sep 2025 |
|
| Ameriprise Financial | 653k | $1.2M | 100% | Sep 2025 |
|
| Two Sigma Investments | 607k | $1.1M | 27% | Sep 2025 |
|
| BlackRock | 450k | $509k | 1% | Dec 2025 |
|
| Renaissance Technologies | 423k | $478k | 157% | Dec 2025 |
|
| Geode Capital Management | 354k | $400k | 0% | Dec 2025 |
|
| Jane Street | 207k | $233k | 14% | Dec 2025 |
|
| Susquehanna International | 184k | $208k | -2% | Dec 2025 |
|
| Northern Trust | 149k | $169k | 57% | Dec 2025 |
|
| State Street Corporation | 124k | $140k | 11% | Dec 2025 |
|
| Seven Fleet Capital Management | 118k | $133k | 100% | Dec 2025 |
|
| Bank of Nova Scotia | 106k | $120k | 0% | Dec 2025 |
|
| GSA Capital Partners | 93k | $105k | 5% | Dec 2025 |
|
| Ieq Capital | 92k | $104k | 0% | Dec 2025 |
|
| Jpmorgan Chase & Co | 62k | $113k | 100% | Sep 2025 |
|
| Citadel Advisors | 58k | $105k | -12% | Sep 2025 |
|
| Nan Fung Trinity | 42k | $47k | 0% | Dec 2025 |
|
| DekaBank Deutsche Girozentrale | 41k | $508k | 0% | Dec 2025 |
|
| Wealth Enhancement Advisory Services | 38k | $41k | 0% | Dec 2025 |
|
| Bridgeway Capital Management | 36k | $66k | 100% | Sep 2025 |
|
| Callan Family Office | 28k | $32k | 43% | Dec 2025 |
|
| Marshall Wace | 26k | $30k | -33% | Dec 2025 |
|
| HC Advisors | 24k | $27k | 9% | Dec 2025 |
|
| Point72 Asset Management | 20k | $23k | 100% | Dec 2025 |
|
| JSF Financial | 18k | $20k | 0% | Dec 2025 |
|
| Goldman Sachs Group | 17k | $20k | -7% | Dec 2025 |
|
| Nine Masts Capital | 16k | $18k | 100% | Dec 2025 |
|
| Moneta Group Investment Advisors | 15k | $17k | 0% | Dec 2025 |
|
| Commonwealth Equity Services | 15k | $17k | -27% | Dec 2025 |
|
| Point72 Asia | 14k | $25k | -50% | Sep 2025 |
|
| Virtu Financial | 14k | $15k | 100% | Dec 2025 |
|
| Lido Advisors | 13k | $24k | 0% | Dec 2025 |
|
| FMR | 13k | $24k | -28% | Sep 2025 |
|
| Abel Hall | 13k | $14k | 0% | Dec 2025 |
|
| Hsbc Holdings | 11k | $19k | -12% | Sep 2025 |
|
| AQR Capital Management | 11k | $20k | -76% | Sep 2025 |
|
| Barclays | 11k | $12k | 0% | Dec 2025 |
|
| Cubist Systematic Strategies | 8.0k | $15k | 100% | Sep 2025 |
|
| Simplex Trading | 3.6k | $4.0k | 100% | Dec 2025 |
|
| Tower Research Capital | 3.1k | $3.6k | -18% | Dec 2025 |
|
| NISA Investment Advisors | 1.1k | $1.3k | 0% | Dec 2025 |
|
| Royal Bank of Canada | 1.1k | $0 | -63% | Sep 2025 |
|
| Bradley & Co. Private Wealth Management | 1.0k | $1.1k | 0% | Dec 2025 |
|
| Group One Trading | 518.00 | $584.977400 | 100% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 480.00 | $542.016000 | 0% | Dec 2025 |
|
| SBI Securities | 422.00 | $772.006800 | 0% | Sep 2025 |
|
| Pnc Financial Services | 100.00 | $113.000000 | 0% | Dec 2025 |
|
| CWM | 96.00 | $0 | -33% | Dec 2025 |
|
| Optiver Holding B.V. | 27.00 | $30.998700 | -4% | Dec 2025 |
|
Who sold out of Alx Oncology Hldgs?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Privium Fund Management B.V. | Sep 2025 | 509k | $932k |
| XTX Topco | Sep 2025 | 27k | $49k |
| Hrt Financial | Sep 2025 | 23k | $41k |
| Qube Research & Technologies | Sep 2025 | 17k | $31k |
| Federated Investors | Sep 2025 | 2.4k | $4.3k |
| Raymond James Financial | Jun 2025 | 1.0k | $415.000000 |
| EverSource Wealth Advisors | Sep 2025 | 499.00 | $914.816700 |